{"id":305,"date":"2018-03-14T15:28:57","date_gmt":"2018-03-14T15:28:57","guid":{"rendered":"http:\/\/syneron-candela.fi\/?p=305"},"modified":"2018-03-14T15:29:27","modified_gmt":"2018-03-14T15:29:27","slug":"syneron-candela-system-picoway-received-fda-clearance-on-resolve-handpiece","status":"publish","type":"post","link":"https:\/\/syneroncandela.fi\/index.php\/2018\/03\/14\/syneron-candela-system-picoway-received-fda-clearance-on-resolve-handpiece\/","title":{"rendered":"Syneron Candela System PicoWay received FDA clearance on \u201cResolve\u201d handpiece"},"content":{"rendered":"<div class=\"post-content\">\n<p>The PicoWay picosecond laser, the very best laser in the market for removing tattoos and treating benign pigmented lesions, has received the FDA\u2019s approval for treating acne scars (I-VI photo-types) using Resolve \u2013 a new exclusive fractional holographic handpiece with 1064 nm wavelength.<\/p>\n<p>By treating acne scars with ultrashort pulses with a high peak power at 1064 nm,\u00a0PicoWay\u00a0Resolve can quickly and effectively improve the surface of the skin with no recovery time or side effects.\u00a0In the development of innovative laser technology, Syneron Candela relies on fundamental clinical research, as well as the needs of patients and their feedback.\u00a0Using the obtained data, Syneron Candela offers only the best solutions for medical clinics, which makes them a competitive manufacturer providing medical care to patients at the highest level.<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>The PicoWay picosecond laser, the very best laser in the market for removing tattoos and treating benign pigmented lesions, has received the FDA\u2019s approval for treating acne scars (I-VI photo-types) using Resolve \u2013 a new exclusive fractional holographic handpiece with 1064 nm wavelength. By treating acne scars with ultrashort pulses with a high peak power [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":306,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_mi_skip_tracking":false,"jetpack_post_was_ever_published":false,"jetpack_publicize_message":"","jetpack_is_tweetstorm":false,"jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":[]},"categories":[22],"tags":[],"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/i0.wp.com\/syneroncandela.fi\/wp-content\/uploads\/2018\/03\/PicoWay_Resolve.jpg?fit=860%2C449&ssl=1","jetpack_sharing_enabled":true,"jetpack_shortlink":"https:\/\/wp.me\/pfCRmh-4V","_links":{"self":[{"href":"https:\/\/syneroncandela.fi\/index.php\/wp-json\/wp\/v2\/posts\/305"}],"collection":[{"href":"https:\/\/syneroncandela.fi\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/syneroncandela.fi\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/syneroncandela.fi\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/syneroncandela.fi\/index.php\/wp-json\/wp\/v2\/comments?post=305"}],"version-history":[{"count":2,"href":"https:\/\/syneroncandela.fi\/index.php\/wp-json\/wp\/v2\/posts\/305\/revisions"}],"predecessor-version":[{"id":335,"href":"https:\/\/syneroncandela.fi\/index.php\/wp-json\/wp\/v2\/posts\/305\/revisions\/335"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/syneroncandela.fi\/index.php\/wp-json\/wp\/v2\/media\/306"}],"wp:attachment":[{"href":"https:\/\/syneroncandela.fi\/index.php\/wp-json\/wp\/v2\/media?parent=305"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/syneroncandela.fi\/index.php\/wp-json\/wp\/v2\/categories?post=305"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/syneroncandela.fi\/index.php\/wp-json\/wp\/v2\/tags?post=305"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}